137 related articles for article (PubMed ID: 2266810)
1. Severe anaphylactoid reaction after i.v. Gd-DTPA.
Weiss KL
Magn Reson Imaging; 1990; 8(6):817-8. PubMed ID: 2266810
[TBL] [Abstract][Full Text] [Related]
2. [Anaphylactoid reaction after intravenous administration of Gd-DTPA].
Katoh A; Kishikawa T; Kudo S; Matsubayashi R; Takagi N; Nishihara G
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Aug; 53(8):973-5. PubMed ID: 8371946
[TBL] [Abstract][Full Text] [Related]
3. Severe anaphylactoid reaction to Gd-DTPA.
Lufkin RB
Radiology; 1990 Sep; 176(3):879. PubMed ID: 2389057
[No Abstract] [Full Text] [Related]
4. Anaphylactoid reactions to i.v. gadopentetate dimeglumine.
Tishler S; Hoffman JC
AJNR Am J Neuroradiol; 1990; 11(6):1167; discussion 1168-9. PubMed ID: 2124049
[No Abstract] [Full Text] [Related]
5. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
6. Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration.
Salonen OL
J Comput Assist Tomogr; 1990; 14(6):912-3. PubMed ID: 2229566
[TBL] [Abstract][Full Text] [Related]
7. Fatal reaction to gadopentetate dimeglumine.
Jordan RM; Mintz RD
AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
[No Abstract] [Full Text] [Related]
8. [A case of anaphylactic shock following the administration of Gd-DTPA].
Nomura M; Takeshita G; Katada K; Nakamura M; Kizukuri T; Ogura Y; Anno H; Koga S
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Dec; 53(12):1387-91. PubMed ID: 8108244
[TBL] [Abstract][Full Text] [Related]
9. Anaphylactic shock induced by intravenous gadopentetate dimeglumine.
Tardy B; Guy C; Barral G; Page Y; Ollagnier M; Bertrand JC
Lancet; 1992 Feb; 339(8791):494. PubMed ID: 1346846
[No Abstract] [Full Text] [Related]
10. Life-threatening anaphylactoid reaction after intravenous gadoteridol administration in a patient who had previously received gadopentetate dimeglumine.
Witte RJ; Anzai LL
AJNR Am J Neuroradiol; 1994 Mar; 15(3):523-4. PubMed ID: 8197951
[TBL] [Abstract][Full Text] [Related]
11. Case report: generalized arthralgia following Gd-DTPA administration.
Wexler DM; Spencer JD
Clin Radiol; 1993 Jul; 48(1):68. PubMed ID: 8370226
[TBL] [Abstract][Full Text] [Related]
12. Laryngospasm after administration of gadopentetate dimeglumine.
Omohundro JE; Elderbrook MK; Ringer TV
J Magn Reson Imaging; 1992; 2(6):729-30. PubMed ID: 1446118
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of dotarem (Gd-DOTA) versus magnevist (Gd-DTPA) in magnetic resonance imaging of the central nervous system.
Oudkerk M; Sijens PE; Van Beek EJ; Kuijpers TJ
Invest Radiol; 1995 Feb; 30(2):75-8. PubMed ID: 7782190
[TBL] [Abstract][Full Text] [Related]
14. Severe adverse reaction to iv gadopentetate dimeglumine.
Takebayashi S; Sugiyama M; Nagase M; Matsubara S
AJR Am J Roentgenol; 1993 Mar; 160(3):659. PubMed ID: 8430574
[No Abstract] [Full Text] [Related]
15. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
Niendorf HP; Haustein J; Louton T; Beck W; Laniado M
Invest Radiol; 1991 Nov; 26 Suppl 1():S221-3; discussion S232-5. PubMed ID: 1808134
[No Abstract] [Full Text] [Related]
16. Pruritus and paresthesia after i.v. administration of Gd-DTPA.
Chan K; Bosanko CM; Wang AM
AJNR Am J Neuroradiol; 1989; 10(5 Suppl):S53. PubMed ID: 2505565
[No Abstract] [Full Text] [Related]
17. In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media.
Baxter AB; Lazarus SC; Brasch RC
Invest Radiol; 1993 Apr; 28(4):308-12. PubMed ID: 7683008
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous nodules, pain, and thrombophlebitis as an adverse reaction to gadolinium contrast media.
Murphy KJ; Hansen R; Prince MR
AJR Am J Roentgenol; 1997 Jul; 169(1):318-9. PubMed ID: 9207574
[No Abstract] [Full Text] [Related]
19. [Comparative studies of the tolerability of gadodiamide, dimeglumine gadopentetate and meglumine gadoterate in MRI tests of the central nervous system].
Chanalet S; Masson B; Boyer L; Laffont J; Bruneton JN
J Radiol; 1995 Jul; 76(7):417-21. PubMed ID: 7473375
[TBL] [Abstract][Full Text] [Related]
20. [Oral contrast media for the magnetic resonance tomography of the abdomen. A clinical trial of the tolerance for gadolinium-DTPA].
Kaminsky S; Laniado M; Gogoll M; Kornmesser W; Clauss W; Felix R
Rofo; 1992 Jan; 156(1):17-23. PubMed ID: 1733470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
